Cite
MLA Citation
Con Panousis et al.. “CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.” MAbs, vol. 8, no. 3, 2016, pp. 436–453. http://access.bl.uk/ark:/81055/vdc_100033828479.0x000011